Aminoglycoside resistance in Pseudomonas aeruginosa
- PMID: 15673721
- PMCID: PMC547279
- DOI: 10.1128/AAC.49.2.479-487.2005
Aminoglycoside resistance in Pseudomonas aeruginosa
Similar articles
-
Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.Microbiologica. 1987 Jan;10(1):103-10. Microbiologica. 1987. PMID: 3106759
-
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2008 Mar;52(3):1173-5. doi: 10.1128/AAC.01212-07. Epub 2008 Jan 7. Antimicrob Agents Chemother. 2008. PMID: 18180356 Free PMC article.
-
Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.Microbiol Immunol. 2008 Aug;52(8):392-8. doi: 10.1111/j.1348-0421.2008.00051.x. Microbiol Immunol. 2008. PMID: 18667038
-
Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents.Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S643-56. doi: 10.1093/clinids/6.supplement_3.s643. Rev Infect Dis. 1984. PMID: 6443766 Review.
-
[Biochemical and genetical mechanisms in emergence of multidrug-resistant Pseudomonas aeruginosa (MDRP)].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:457-62. Nihon Rinsho. 2007. PMID: 17455662 Review. Japanese. No abstract available.
Cited by
-
Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.PLoS One. 2013 Jul 22;8(7):e68484. doi: 10.1371/journal.pone.0068484. Print 2013. PLoS One. 2013. PMID: 23894309 Free PMC article.
-
Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India.Indian J Pharmacol. 2008 Oct;40(5):230-4. doi: 10.4103/0253-7613.44156. Indian J Pharmacol. 2008. PMID: 20040963 Free PMC article.
-
A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae.Antimicrob Agents Chemother. 2022 May 17;66(5):e0025122. doi: 10.1128/aac.00251-22. Epub 2022 Apr 25. Antimicrob Agents Chemother. 2022. PMID: 35465683 Free PMC article.
-
Arctic Psychrotolerant Pseudomonas sp. B14-6 Exhibits Temperature-Dependent Susceptibility to Aminoglycosides.Antibiotics (Basel). 2022 Jul 29;11(8):1019. doi: 10.3390/antibiotics11081019. Antibiotics (Basel). 2022. PMID: 36009888 Free PMC article.
-
Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis.Clin Med Insights Circ Respir Pulm Med. 2013 Nov 13;7:61-77. doi: 10.4137/CCRPM.S10592. Clin Med Insights Circ Respir Pulm Med. 2013. PMID: 24324354 Free PMC article. Review.
References
-
- Alexandrakis, G., E. C. Alfonso, and D. Miller. 2000. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497-1502. - PubMed
-
- Alvarez, M., and M. C. Mendoza. 1993. Molecular epidemiology of two genes encoding 3-N-aminoglycoside acetyltransferases AAC(3)I and AAC(3)II among gram-negative bacteria from a Spanish hospital. Eur. J. Epidemiol. 9:650-657. - PubMed
-
- Andrade, S. S., R. N. Jones, A. C. Gales, and H. S. Sader. 2003. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J. Antimicrob. Chemother. 52:140-141. - PubMed
-
- Angelatou, F., S. B. Litsas, and P. Kontomichalou. 1982. Purification and properties of two gentamicin-modifying enzymes, coded by a single plasmid pPK237 originating from Pseudomonas aeruginosa. J. Antibiot. (Tokyo) 35:235-244. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical